218 related articles for article (PubMed ID: 35328014)
21. Aspirin and the prevention of colorectal cancer.
Ferrández A; Piazuelo E; Castells A
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):185-95. PubMed ID: 22542156
[TBL] [Abstract][Full Text] [Related]
22. Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer.
Kloth M; Ruesseler V; Engel C; Koenig K; Peifer M; Mariotti E; Kuenstlinger H; Florin A; Rommerscheidt-Fuss U; Koitzsch U; Wodtke C; Ueckeroth F; Holzapfel S; Aretz S; Propping P; Loeffler M; Merkelbach-Bruse S; Odenthal M; Friedrichs N; Heukamp LC; Zander T; Buettner R
Gut; 2016 Aug; 65(8):1296-305. PubMed ID: 26001389
[TBL] [Abstract][Full Text] [Related]
23. Aspirin in the Prevention of Colorectal Neoplasia.
Drew DA; Chan AT
Annu Rev Med; 2021 Jan; 72():415-430. PubMed ID: 33035431
[TBL] [Abstract][Full Text] [Related]
24. RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.
Tuccori M; Filion KB; Azoulay L
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711870
[No Abstract] [Full Text] [Related]
25. Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up.
Mathers JC; Elliott F; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar RS; Seppälä TT; Thomas HJW; Sheth HJ; Pylvänäinen K; Reed L; Borthwick GM; Bishop DT; Burn J;
Cancer Prev Res (Phila); 2022 Sep; 15(9):623-634. PubMed ID: 35878732
[TBL] [Abstract][Full Text] [Related]
26. Aspirin may help colon cancer patients live longer.
Harv Health Lett; 2013 Jan; 38(3):8. PubMed ID: 23556168
[No Abstract] [Full Text] [Related]
27. Aspirin for the prevention of colorectal cancer.
Garcia-Albeniz X; Chan AT
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):461-72. PubMed ID: 22122763
[TBL] [Abstract][Full Text] [Related]
28. European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender.
Seppälä TT; Latchford A; Negoi I; Sampaio Soares A; Jimenez-Rodriguez R; Sánchez-Guillén L; Evans DG; Ryan N; Crosbie EJ; Dominguez-Valentin M; Burn J; Kloor M; Knebel Doeberitz MV; Duijnhoven FJBV; Quirke P; Sampson JR; Møller P; Möslein G;
Br J Surg; 2021 May; 108(5):484-498. PubMed ID: 34043773
[TBL] [Abstract][Full Text] [Related]
29. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
30. Does aspirin really reduce the risk of colon cancer?
Cleland JG
Lancet; 2012 Apr; 379(9826):1586; author reply 1587. PubMed ID: 22541575
[No Abstract] [Full Text] [Related]
31. Does aspirin really reduce the risk of colon cancer?
Jankowski J; Barr H; Moayyedi P
Lancet; 2012 Apr; 379(9826):1586-7; author reply 1587. PubMed ID: 22541573
[No Abstract] [Full Text] [Related]
32. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ;
J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455
[TBL] [Abstract][Full Text] [Related]
33. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
[TBL] [Abstract][Full Text] [Related]
34. Colorectal Cancer Screening Recommendations and Outcomes in Lynch Syndrome.
Drogan C; Kupfer SS
Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):59-74. PubMed ID: 34798987
[TBL] [Abstract][Full Text] [Related]
35. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP
J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893
[TBL] [Abstract][Full Text] [Related]
36. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
[TBL] [Abstract][Full Text] [Related]
37. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV
JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951
[TBL] [Abstract][Full Text] [Related]
38. CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome.
Ahadova A; von Knebel Doeberitz M; Bläker H; Kloor M
Fam Cancer; 2016 Oct; 15(4):579-86. PubMed ID: 26960970
[TBL] [Abstract][Full Text] [Related]
39. What is the appropriate screening protocol in Lynch syndrome?
de Jong AE; Nagengast FM; Kleibeuker JH; van de Meeberg PC; van Wijk HJ; Cats A; Griffioen G; Vasen HF
Fam Cancer; 2006; 5(4):373-8. PubMed ID: 16826316
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N;
Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
